Structure and Function of ABCG2-Rich Extracellular Vesicles Mediating Multidrug Resistance | PLOS ONE
![Identification of a urate transporter, ABCG2, with a common functional polymorphism causing gout | PNAS Identification of a urate transporter, ABCG2, with a common functional polymorphism causing gout | PNAS](https://www.pnas.org/cms/10.1073/pnas.0901249106/asset/359f17a0-e0b2-476a-9505-093795a1fe00/assets/graphic/zpq9990983790004.jpeg)
Identification of a urate transporter, ABCG2, with a common functional polymorphism causing gout | PNAS
![Inhibition of ABCG2 efflux pumps renders the Mycobacterium tuberculosis hiding in mesenchymal stem cells responsive to antibiotic treatment - ScienceDirect Inhibition of ABCG2 efflux pumps renders the Mycobacterium tuberculosis hiding in mesenchymal stem cells responsive to antibiotic treatment - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1567134820304937-ga1.jpg)
Inhibition of ABCG2 efflux pumps renders the Mycobacterium tuberculosis hiding in mesenchymal stem cells responsive to antibiotic treatment - ScienceDirect
![IJMS | Free Full-Text | Medically Important Alterations in Transport Function and Trafficking of ABCG2 IJMS | Free Full-Text | Medically Important Alterations in Transport Function and Trafficking of ABCG2](https://www.mdpi.com/ijms/ijms-22-02786/article_deploy/html/images/ijms-22-02786-g001-550.jpg)
IJMS | Free Full-Text | Medically Important Alterations in Transport Function and Trafficking of ABCG2
![BCRP/ABCG2 and high-alert medications: Biochemical, pharmacokinetic, pharmacogenetic, and clinical implications - ScienceDirect BCRP/ABCG2 and high-alert medications: Biochemical, pharmacokinetic, pharmacogenetic, and clinical implications - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0006295217306342-fx1.jpg)
BCRP/ABCG2 and high-alert medications: Biochemical, pharmacokinetic, pharmacogenetic, and clinical implications - ScienceDirect
![Lazertinib improves the efficacy of chemotherapeutic drugs in ABCB1 or ABCG2 overexpression cancer cells in vitro, in vivo, and ex vivo: Molecular Therapy - Oncolytics Lazertinib improves the efficacy of chemotherapeutic drugs in ABCB1 or ABCG2 overexpression cancer cells in vitro, in vivo, and ex vivo: Molecular Therapy - Oncolytics](https://www.cell.com/cms/attachment/122bd482-b06a-4188-8b50-4b310e91b1cd/fx1_lrg.jpg)
Lazertinib improves the efficacy of chemotherapeutic drugs in ABCB1 or ABCG2 overexpression cancer cells in vitro, in vivo, and ex vivo: Molecular Therapy - Oncolytics
![New Inhibitors of Breast Cancer Resistance Protein (ABCG2) Containing a 2,4-Disubstituted Pyridopyrimidine Scaffold | Journal of Medicinal Chemistry New Inhibitors of Breast Cancer Resistance Protein (ABCG2) Containing a 2,4-Disubstituted Pyridopyrimidine Scaffold | Journal of Medicinal Chemistry](https://pubs.acs.org/cms/10.1021/acs.jmedchem.7b01012/asset/images/large/jm-2017-010126_0013.jpeg)
New Inhibitors of Breast Cancer Resistance Protein (ABCG2) Containing a 2,4-Disubstituted Pyridopyrimidine Scaffold | Journal of Medicinal Chemistry
![Human ABC Transporter ABCG2 in Cancer Chemotherapy: Drug Molecular Design to Circumvent Multidrug Resistance | SpringerLink Human ABC Transporter ABCG2 in Cancer Chemotherapy: Drug Molecular Design to Circumvent Multidrug Resistance | SpringerLink](https://media.springernature.com/lw685/springer-static/image/chp%3A10.1007%2F978-1-61779-965-5_11/MediaObjects/211646_2_En_11_Fig1_HTML.gif)
Human ABC Transporter ABCG2 in Cancer Chemotherapy: Drug Molecular Design to Circumvent Multidrug Resistance | SpringerLink
![Frontiers | Inhibitors of Human ABCG2: From Technical Background to Recent Updates With Clinical Implications Frontiers | Inhibitors of Human ABCG2: From Technical Background to Recent Updates With Clinical Implications](https://www.frontiersin.org/files/Articles/445264/fphar-10-00208-HTML/image_m/fphar-10-00208-g001.jpg)
Frontiers | Inhibitors of Human ABCG2: From Technical Background to Recent Updates With Clinical Implications
![Frontiers | Inhibitors of Human ABCG2: From Technical Background to Recent Updates With Clinical Implications Frontiers | Inhibitors of Human ABCG2: From Technical Background to Recent Updates With Clinical Implications](https://www.frontiersin.org/files/Articles/445264/fphar-10-00208-HTML/image_m/fphar-10-00208-g002.jpg)
Frontiers | Inhibitors of Human ABCG2: From Technical Background to Recent Updates With Clinical Implications
![Polymorphisms of the Multidrug Pump ABCG2: A Systematic Review of Their Effect on Protein Expression, Function, and Drug Pharmacokinetics | Drug Metabolism & Disposition Polymorphisms of the Multidrug Pump ABCG2: A Systematic Review of Their Effect on Protein Expression, Function, and Drug Pharmacokinetics | Drug Metabolism & Disposition](https://dmd.aspetjournals.org/sites/default/files/highwire/dmd/46/12.cover-source.jpg)
Polymorphisms of the Multidrug Pump ABCG2: A Systematic Review of Their Effect on Protein Expression, Function, and Drug Pharmacokinetics | Drug Metabolism & Disposition
![The ABCG2 multidrug transporter is a pump gated by a valve and an extracellular lid | Nature Communications The ABCG2 multidrug transporter is a pump gated by a valve and an extracellular lid | Nature Communications](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41467-019-13302-2/MediaObjects/41467_2019_13302_Fig1_HTML.png)
The ABCG2 multidrug transporter is a pump gated by a valve and an extracellular lid | Nature Communications
![Cancers | Free Full-Text | VKNG-1 Antagonizes ABCG2-Mediated Multidrug Resistance via p-AKT and Bcl-2 Pathway in Colon Cancer: In Vitro and In Vivo Study Cancers | Free Full-Text | VKNG-1 Antagonizes ABCG2-Mediated Multidrug Resistance via p-AKT and Bcl-2 Pathway in Colon Cancer: In Vitro and In Vivo Study](https://pub.mdpi-res.com/cancers/cancers-13-04675/article_deploy/html/images/cancers-13-04675-ag.png?1633659577)
Cancers | Free Full-Text | VKNG-1 Antagonizes ABCG2-Mediated Multidrug Resistance via p-AKT and Bcl-2 Pathway in Colon Cancer: In Vitro and In Vivo Study
![The roles of breast cancer resistance protein (BCRP/ABCG2) and multidrug resistance-associated proteins (MRPs/ABCCs) in the excretion of cycloicaritin-3-O-glucoronide in UGT1A1-overexpressing HeLa cells - ScienceDirect The roles of breast cancer resistance protein (BCRP/ABCG2) and multidrug resistance-associated proteins (MRPs/ABCCs) in the excretion of cycloicaritin-3-O-glucoronide in UGT1A1-overexpressing HeLa cells - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0009279718306306-fx1.jpg)
The roles of breast cancer resistance protein (BCRP/ABCG2) and multidrug resistance-associated proteins (MRPs/ABCCs) in the excretion of cycloicaritin-3-O-glucoronide in UGT1A1-overexpressing HeLa cells - ScienceDirect
![Asperjinone, a Nor-Neolignan, and Terrein, a Suppressor of ABCG2-Expressing Breast Cancer Cells, from Thermophilic Aspergillus terreus | Journal of Natural Products Asperjinone, a Nor-Neolignan, and Terrein, a Suppressor of ABCG2-Expressing Breast Cancer Cells, from Thermophilic Aspergillus terreus | Journal of Natural Products](https://pubs.acs.org/cms/10.1021/np200866z/asset/images/medium/np-2011-00866z_0004.gif)
Asperjinone, a Nor-Neolignan, and Terrein, a Suppressor of ABCG2-Expressing Breast Cancer Cells, from Thermophilic Aspergillus terreus | Journal of Natural Products
![Effects of ATP-binding cassette transporter G2 in extracellular vesicles on drug resistance of laryngeal cancer cells in <em>in vivo</em> and <em>in vitro</em> Effects of ATP-binding cassette transporter G2 in extracellular vesicles on drug resistance of laryngeal cancer cells in <em>in vivo</em> and <em>in vitro</em>](https://www.spandidos-publications.com/article_images/ol/21/5/ol-21-05-12625-g00.jpg)